These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 3902711

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Adverse effects of summer amongst people with learning disabilities: neuroleptic malignant syndrome.
    Fitzgerald B, Middleton JK, Cooper SA.
    J Intellect Disabil Res; 1997 Jun; 41 ( Pt 3)():273-7. PubMed ID: 9219078
    [Abstract] [Full Text] [Related]

  • 43. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS, Walker R, Shill HA.
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Could you spot this psych emergency?
    Weitzel C.
    RN; 2000 Sep; 63(9):35-8; quiz 40. PubMed ID: 11040780
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Electroconvulsive therapy in drug resistant neuroleptic malignant syndrome.
    Patel AL, Shaikh WA, Khobragade AK, Soni HG, Joshi AS, Sahastrabuddhe GS.
    J Assoc Physicians India; 2008 Jan; 56():49-50. PubMed ID: 18472502
    [Abstract] [Full Text] [Related]

  • 49. [Neuroleptic malignant syndrome with rhabdomyolysis and compartment syndrome].
    Solders G, Hedlund R, Engvall P, Wernerman J.
    Lakartidningen; 1988 Feb 10; 85(6):445, 447. PubMed ID: 3352421
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD, Ponce FA, Killory BD, Wallace D, Rekate HL.
    J Neurosurg Pediatr; 2009 Sep 10; 4(3):217-21. PubMed ID: 19772404
    [Abstract] [Full Text] [Related]

  • 52. Risperidone-induced hyperamylasemia, hyperlipasemia, and neuroleptic malignant syndrome: a case report.
    Ghio L, Fornaro G, Rossi P.
    J Clin Psychopharmacol; 2009 Aug 10; 29(4):391-2. PubMed ID: 19593182
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Malignant neuroleptic syndrome].
    Segado Soriano A, López Gonzalez-Cobos C, Villalba Garciá MV, Gil Gómez J, Muiño Miguez A, Millan Núñez-Cortés J.
    An Med Interna; 1997 May 10; 14(5):231-5. PubMed ID: 9235098
    [Abstract] [Full Text] [Related]

  • 57. [Malignant neuroleptic syndrome].
    Suchanová L.
    Cesk Psychiatr; 1985 Apr 10; 81(2):91-5. PubMed ID: 4017050
    [No Abstract] [Full Text] [Related]

  • 58. Neuroleptic malignant syndrome revisited!
    Qureshi NA.
    Saudi Med J; 2002 Sep 10; 23(9):1147; author reply 1147-8. PubMed ID: 12370736
    [No Abstract] [Full Text] [Related]

  • 59. [The neuroleptic malignant syndrome].
    Selva A, San José A, Jacas C, Vilardell M.
    Med Clin (Barc); 1994 Oct 29; 103(14):557. PubMed ID: 7799671
    [No Abstract] [Full Text] [Related]

  • 60. Idiopathic hypoparathyroidism presenting as the neuroleptic malignant syndrome.
    Lim R.
    Br J Hosp Med; 1989 Feb 29; 41(2):182. PubMed ID: 2713570
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.